Lung cancer clinician-researcher presents treatment breakthrough at world’s largest cancer conference
An Australian-first clinical trial has drawn global attention, with early results presented at the world’s largest oncology conference.
Using existing medicines to help the immune system fight ovarian cancer
A key challenge in treating ovarian cancer is the immune system’s inability to recognise and attack tumour cells.
Monash Health named Outstanding Clinical Trial Site by gynaecological cancer peak body
New blood cancer drug shows promising results in global trial
A groundbreaking international study has revealed that a new drug, luspatercept, significantly outperforms the current standard treatment for anaemia in patients with lower-risk myelodysplastic syndromes (MDS). The COMMANDS trial analysed the difference between the drugs luspatercept and epoetin alfa, which is the current standard treatment.
Media: new PBS-listed medication for rare and aggressive lung cancer
Monash Haematology successfully performs first outpatient stem cell transplant
Monash Haematology has reached an exciting milestone – successfully performing its first outpatient stem cell transplant for a patient with multiple myeloma, a type of blood cancer. Autologous stem cell transplant (ASCT) is a standard frontline treatment for multiple myeloma. The process involves collecting the patient’s own stem cells, administering high dose chemotherapy and reinfusing the stem cells to restore healthy blood cell production.
Life-saving therapy for bone marrow blood cancer sees remission rates increase
An intense but potentially life-saving treatment aimed at eliminating leukaemia cells and achieving remission for a type of blood cancer that originates from bone marrow has seen success at Monash Health. The significant milestone was recorded in a 5-year study that oversaw the treatment of 58 patients who had been newly diagnosed with Acute Myeloid Leukemia (AML).
Clinician-scientist awarded Michael Friedlander AM 2025 Award for ovarian cancer research
Dr Gwo-Yaw Ho, a clinician-scientist at Monash Health and the School of Clinical Sciences at Monash University, has been awarded the 2025 Michael Friedlander AM Award by the Australia New Zealand Gynaecological Oncology Group (ANZGOG). This prestigious award, recognising an early-career researcher who has significantly advanced the field of gynaecological cancer, was announced on 6 March 2025 during the ANZGOG Annual Scientific Meeting Conference Dinner, held at the National Gallery of Australia.
Monash Health’s groundbreaking diagnostic tool gives hope to blood cancer patients
An evolving technology that can screen for more than 600 different gene fusions (two or more genes joined together) in a single test, has been approved as a diagnostic tool at Monash Health. A study by a team of researchers at Monash Health confirms that the next-generation sequencing (NGS) RNA (messenger carrying instructions from DNA) fusion panel reliably identified gene arrangements that drive blood cancers.